HFS
TXG icon

Hughes Financial Services’s 10x Genomics TXG Stock Holding History

Hughes Financial Services’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-46
Closed -$399 – 1228
2025
Q1 		$399 Buy
+46
New +$580 ﹤0.01% 1013

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hughes Financial Services's TXG Position: Q2 2025 in Review

Hughes Financial Services sold out of 10x Genomics (TXG) in Q2 2025, closing a stake of 46 shares — an estimated $399 sold.

Hughes Financial Services first reported a position in TXG in Q1 2025 and held it in 1 quarter. The position peaked at $399 in Q1 2025. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

  • Hughes Financial Services reported no remaining 10x Genomics position as of Q2 2025 after selling out during the quarter.
  • Hughes Financial Services sold 46 10x Genomics shares in Q2 2025, an estimated $399.
  • Hughes Financial Services first reported a position in 10x Genomics in Q1 2025 and held it in 1 quarter.
  • Hughes Financial Services's 10x Genomics position peaked at $399 in Q1 2025.
  • 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on Hughes Financial Services's 13F filing for Q2 2025, filed 7 Aug 2025.